This invention provides a compound of formulae (I) or (II) having the structure
##STR1##
or a pharmaceutically acceptable salt thereof which are useful for the treatment
of the inflammatory component of diseases and are particularly useful in treating
atherosclerosis, myocardial infarction, congestive heart failure, inflammatory
bowel disease, arthritis, type II diabetes, and autoimmune diseases such as multiple
sclerosis and rheumatiod arthritis.
